AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo
Abstract Background Pancreatic cancer is a malignant disease with a poor prognosis. Gemcitabine (GEM), the first-line treatment drug, shows limited efficacy because of the notorious drug resistance of pancreatic cancer. Therefore, the development of sensitive drugs for pancreatic cancer is essential...
Збережено в:
| Автори: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-08-01
|
| Серія: | Cancer Cell International |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12935-025-03952-2 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|